Company Data
Syndax Pharmaceuticals Inc.
Ticker
SNDX
Current Price
$23.52 3.84%
Market Cap
$2.0B
Price Target
Refer to Report
Volume
3.6M
52wk Range
$11.215 - $25.34
Overview
Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company’s product candidate are entinostat which has direct effects on both cancer cells and immune regulatory cells, and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body’s immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.